Bahadoran Zahra, Mirmiran Parvin, Ghasemi Asghar, Carlström Mattias, Azizi Fereidoun, Hadaegh Farzad
Nutrition and Endocrine Research Center, Research Institute for Endocrine Sciences, Shahid Beheshti University of Medical Sciences, Tehran 19395-4763, Iran.
Endocrine Physiology Research Center, Research Institute for Endocrine Sciences, Shahid Beheshti University of Medical Sciences, Tehran 19395-4763, Iran.
Nutrients. 2016 Dec 21;8(12):811. doi: 10.3390/nu8120811.
The association of habitual intakes of dietary nitrate (NO₃) and nitrite (NO₂) with blood pressure and renal function is not clear. Here, we investigated a potential effect of dietary NO₃ and NO₂ on the occurrence of hypertension (HTN) and chronic kidney disease (CKD).
A total of 2799 Iranian adults aged ≥20 years, participating in the Tehran Lipid and Glucose Study (TLGS), were included and followed for a median of 5.8 years. Dietary intakes of NO₃ and NO₂ were estimated using a semi-quantitative food frequency questionnaire. Demographics, anthropometrics, blood pressure and biochemical variables were evaluated at baseline and during follow-up examinations. To identify the odds ratio (OR) and 95% confidence interval (CI) of HTN and CKD across tertile categories of residual energy-adjusted NO₃ and NO₂ intakes, multivariate logistic regression models were used.
Dietary intake of NO₃ had no significant association with the risk of HTN or CKD. Compared to the lowest tertile category (median intake < 6.04 mg/day), the highest intake (median intake ≥ 12.7 mg/day) of dietary NO₂ was accompanied with a significant reduced risk of HTN, in the fully adjusted model (OR = 0.58, 95% CI = 0.33-0.98; for trend = 0.054). The highest compared to the lowest tertile of dietary NO₂ was also accompanied with a reduced risk of CKD (OR = 0.50, 95% CI = 0.24-0.89, for trend = 0.07).
Our findings indicated that higher intakes of NO₂ might be an independent dietary protective factor against the development of HTN and CKD, which are major risk factors for adverse cardiovascular events.
膳食硝酸盐(NO₃)和亚硝酸盐(NO₂)的习惯性摄入量与血压及肾功能之间的关联尚不清楚。在此,我们研究了膳食NO₃和NO₂对高血压(HTN)和慢性肾脏病(CKD)发生的潜在影响。
共有2799名年龄≥20岁的伊朗成年人参与了德黑兰血脂与血糖研究(TLGS),并对他们进行了为期5.8年的随访。使用半定量食物频率问卷估算膳食NO₃和NO₂的摄入量。在基线和随访检查时评估人口统计学、人体测量学、血压和生化变量。为了确定残余能量调整后的NO₃和NO₂摄入量三分位数类别中HTN和CKD的比值比(OR)及95%置信区间(CI),使用了多因素逻辑回归模型。
膳食NO₃摄入量与HTN或CKD风险无显著关联。与最低三分位数类别(中位数摄入量<6.04毫克/天)相比,膳食NO₂的最高摄入量(中位数摄入量≥12.7毫克/天)在完全调整模型中与HTN风险显著降低相关(OR = 0.58,95% CI = 0.33 - 0.98;趋势P = 0.054)。膳食NO₂最高三分位数与最低三分位数相比,CKD风险也降低(OR = 0.50,95% CI = 0.24 - 0.89,趋势P = 0.07)。
我们的研究结果表明,较高的NO₂摄入量可能是预防HTN和CKD发生的独立膳食保护因素,而HTN和CKD是不良心血管事件的主要危险因素。